44 related articles for article (PubMed ID: 29479063)
1. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract][Full Text] [Related]
2. Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach.
Shafie A; Khan S; Batra S; Anjum F; Mohammad T; Alam S; Yadav DK; Islam A; Hassan MI
PLoS One; 2021; 16(10):e0258929. PubMed ID: 34679086
[TBL] [Abstract][Full Text] [Related]
3. CANCER. The oncogene makes its escape.
Wala J; Beroukhim R
Science; 2016 Mar; 351(6280):1398-9. PubMed ID: 27013717
[No Abstract] [Full Text] [Related]
4. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
[TBL] [Abstract][Full Text] [Related]
5. Targeting PIM Kinases to Improve the Efficacy of Immunotherapy.
Clements AN; Warfel NA
Cells; 2022 Nov; 11(22):. PubMed ID: 36429128
[TBL] [Abstract][Full Text] [Related]
6. UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression.
Hu A; Gao J; Varier KM; Gajendran B; Jiang F; Liu W; Wang C; Xiao X; Li Y; Zacksenhaus E; Ali S; Ben-David Y
Cell Death Discov; 2022 Nov; 8(1):448. PubMed ID: 36335089
[TBL] [Abstract][Full Text] [Related]
7. A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia.
Pierini V; Bardelli V; Giglio F; Arniani S; Matteucci C; Pellanera F; Quintini M; Crescenzi B; Bruno A; Sabattini E; Falcinelli E; Ruggeri L; Ronchi P; Ponzoni M; Ciceri F; Mecucci C; La Starza R
Hemasphere; 2022 Nov; 6(11):e795. PubMed ID: 36285071
[No Abstract] [Full Text] [Related]
8. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.
Cordo' V; van der Zwet JCG; Canté-Barrett K; Pieters R; Meijerink JPP
Blood Cancer Discov; 2021 Jan; 2(1):19-31. PubMed ID: 34661151
[TBL] [Abstract][Full Text] [Related]
9. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
Bardelli V; Arniani S; Pierini V; Di Giacomo D; Pierini T; Gorello P; Mecucci C; La Starza R
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440292
[TBL] [Abstract][Full Text] [Related]
10. NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
Catherinet C; Passaro D; Gachet S; Medyouf H; Reynaud A; Lasgi C; Ghysdael J; Tran Quang C
PLoS One; 2021; 16(7):e0254184. PubMed ID: 34234374
[TBL] [Abstract][Full Text] [Related]
11. Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia.
Johansson P; Dierichs L; Klein-Hitpass L; Bergmann AK; Möllmann M; Menninger S; Habenberger P; Klebl B; Siveke JT; Dührsen U; Choidas A; Dürig J
Ther Adv Hematol; 2020; 11():2040620720933761. PubMed ID: 33117517
[TBL] [Abstract][Full Text] [Related]
12. PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis.
Lim JT; Singh N; Leuvano LA; Calvert VS; Petricoin EF; Teachey DT; Lock RB; Padi M; Kraft AS; Padi SKR
Mol Cancer Ther; 2020 Sep; 19(9):1809-1821. PubMed ID: 32753387
[TBL] [Abstract][Full Text] [Related]
13. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects.
Fattizzo B; Rosa J; Giannotta JA; Baldini L; Fracchiolla NS
Front Oncol; 2020; 10():273. PubMed ID: 32185137
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.
De Smedt R; Peirs S; Morscio J; Matthijssens F; Roels J; Reunes L; Lintermans B; Goossens S; Lammens T; Van Roy N; Touzart A; Jenni S; Tsai YC; Lovisa F; Mussolin L; Serafin V; Van Nieuwerburgh F; Deforce D; Uyttebroeck A; Tousseyn T; Burkhardt B; Klapper W; De Moerloose B; Benoit Y; Macintyre E; Bourquin JP; Basso G; Accordi B; Bornhauser B; Meijerink J; Vandenberghe P; Van Vlierberghe P
Haematologica; 2019 Jan; 104(1):e17-e20. PubMed ID: 30076176
[No Abstract] [Full Text] [Related]
15. High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement.
La Starza R; Messina M; Gianfelici V; Pierini V; Matteucci C; Pierini T; Limongi MZ; Vitale A; Roti G; Chiaretti S; Foà R; Mecucci C
Leukemia; 2018 Aug; 32(8):1807-1810. PubMed ID: 29479063
[No Abstract] [Full Text] [Related]
16. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
Padi SKR; Luevano LA; An N; Pandey R; Singh N; Song JH; Aster JC; Yu XZ; Mehrotra S; Kraft AS
Oncotarget; 2017 May; 8(18):30199-30216. PubMed ID: 28415816
[TBL] [Abstract][Full Text] [Related]
17. PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.
Szydłowski M; Dębek S; Prochorec-Sobieszek M; Szołkowska M; Tomirotti AM; Juszczyński P; Szumera-Ciećkiewicz A
Am J Pathol; 2021 Mar; 191(3):567-574. PubMed ID: 33307035
[TBL] [Abstract][Full Text] [Related]
18. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P
Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407
[TBL] [Abstract][Full Text] [Related]
19. T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature.
Sugimoto KJ; Shimada A; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(5):2615-23. PubMed ID: 24966976
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
